Peptide Libraray

Sequence 3 from Patent US 20120302729

General Information

DCTPep ID DCTPep01413

Peptide Name Sequence 3 from Patent US 20120302729

Sequence KAMQDAEVSKSDIGEVI

Sequence Length 17

UniProt ID Q5R511 O35501 Q3ZCH0 P38647 P38646 Q5ZM98

PubChem CID Not available

Origin Synthetic construct

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure DCTPep01413

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification Not available

Other Modification None

Chiral L

Physicochemical Information

Formula C76H130N20O29S1

Absent amino acids CFHLNPRTWY

Theoretical pI 4.32

Acidic residues 4

Basic residues 2

Polar residues 3

Molecular weight (Average) 1820.04

Molecular weight (Monoisotopic) 1818.9

Common amino acids ADEIKSV

Net charge -2

Instability index (II) 11.87

Aliphatic index 91.76

Grand average of hydropathicity (GRAVY) -0.259

Half Life
1.3 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
3 min (Escherichia coli, in vivo).

Extinction coefficients
Should not be visible by UV spectrophotometry.

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2012/0302729 A1

Patent Title Anticancer anti-mortalin peptide antibody.

Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013

Other Published ID EP2511371A1 EP2511371A4